The Clorox Company $CLX Shares Sold by Delta Global Management LP

Delta Global Management LP lessened its position in shares of The Clorox Company (NYSE:CLX) by 73.6% during the 4th quarter, Holdings Channel reports. The institutional investor owned 5,354 shares of the company’s stock after selling 14,917 shares during the period. Delta Global Management LP’s holdings in Clorox were worth $540,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently bought and sold shares of the business. Wilkins Investment Counsel Inc. raised its position in Clorox by 250.6% during the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock worth $5,552,000 after acquiring an additional 39,360 shares during the period. JPMorgan Chase & Co. raised its position in Clorox by 27.0% during the third quarter. JPMorgan Chase & Co. now owns 928,654 shares of the company’s stock worth $114,506,000 after acquiring an additional 197,330 shares during the period. Morningstar Investment Management LLC raised its position in Clorox by 131.8% during the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after acquiring an additional 35,506 shares during the period. Swiss Life Asset Management Ltd raised its position in Clorox by 221.4% during the third quarter. Swiss Life Asset Management Ltd now owns 86,426 shares of the company’s stock worth $10,656,000 after acquiring an additional 59,533 shares during the period. Finally, Birch Hill Investment Advisors LLC purchased a new stake in Clorox during the 4th quarter worth approximately $22,103,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Buying and Selling at Clorox

In related news, Director Pierre R. Breber purchased 5,000 shares of Clorox stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 0.63% of the company’s stock.

Clorox Stock Performance

Clorox stock opened at $97.52 on Wednesday. The firm has a 50 day simple moving average of $96.26 and a 200-day simple moving average of $105.05. The Clorox Company has a 1-year low of $84.70 and a 1-year high of $132.03. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The stock has a market cap of $11.79 billion, a price-to-earnings ratio of 15.83, a price-to-earnings-growth ratio of 0.50 and a beta of 0.56.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts expect that The Clorox Company will post 5.61 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have commented on CLX shares. Evercore reiterated an “underperform” rating and set a $110.00 price objective on shares of Clorox in a research note on Friday, May 1st. Jefferies Financial Group lowered their target price on shares of Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a research note on Tuesday, May 12th. BNP Paribas Exane lowered their target price on shares of Clorox from $128.00 to $97.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 12th. Finally, Wells Fargo & Company decreased their target price on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. One equities research analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Reduce” and an average price target of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.